Insulet Corp. diskutieren
Insulet Corp.
WKN: A0MQX8 / Symbol: PODD / Name: Insulet / Aktie / Ausrüstung & Versorgung / Mid Cap /
242,20 €
-1,49 %
Insulet Co. (NASDAQ: PODD) had its price target raised by analysts at Raymond James from $213.00 to $260.00. They now have an "outperform" rating on the stock.
Ratings data for PODD provided by MarketBeat
Insulet Co. (NASDAQ: PODD) is now covered by analysts at Sanford C. Bernstein. They set an "outperform" rating and a $300.00 price target on the stock.
Ratings data for PODD provided by MarketBeat
Insulet Co. (NASDAQ: PODD) had its price target raised by analysts at BTIG Research from $260.00 to $270.00. They now have a "buy" rating on the stock.
Ratings data for PODD provided by MarketBeat
Insulet Co. (NASDAQ: PODD) had its price target raised by analysts at Morgan Stanley from $234.00 to $317.00. They now have an "overweight" rating on the stock.
Ratings data for PODD provided by MarketBeat
Insulet Co. (NASDAQ: PODD) had its price target raised by analysts at Wells Fargo & Company from $290.00 to $305.00. They now have an "overweight" rating on the stock.
Ratings data for PODD provided by MarketBeat
Insulet Co. (NASDAQ: PODD) had its price target raised by analysts at Citigroup Inc. from $283.00 to $310.00. They now have a "buy" rating on the stock.
Ratings data for PODD provided by MarketBeat
Insulet Co. (NASDAQ: PODD) had its price target raised by analysts at JPMorgan Chase & Co. from $280.00 to $330.00. They now have an "overweight" rating on the stock.
Ratings data for PODD provided by MarketBeat
Insulet Co. (NASDAQ: PODD) had its price target raised by analysts at TD Cowen from $264.00 to $324.00. They now have a "buy" rating on the stock.
Ratings data for PODD provided by MarketBeat
Insulet Co. (NASDAQ: PODD) had its price target raised by analysts at Wells Fargo & Company from $305.00 to $322.00. They now have an "overweight" rating on the stock.
Ratings data for PODD provided by MarketBeat
Insulet Co. (NASDAQ: PODD) had its price target raised by analysts at Piper Sandler from $285.00 to $310.00. They now have an "overweight" rating on the stock.
Ratings data for PODD provided by MarketBeat
Insulet Co. (NASDAQ: PODD) had its "outperform" rating re-affirmed by analysts at Raymond James. They now have a $328.00 price target on the stock, up previously from $294.00.
Ratings data for PODD provided by MarketBeat
Insulet Co. (NASDAQ: PODD) had its price target raised by analysts at Citigroup Inc. from $310.00 to $355.00. They now have a "buy" rating on the stock.
Ratings data for PODD provided by MarketBeat
Insulet Co. (NASDAQ: PODD) is now covered by analysts at Royal Bank of Canada. They set an "outperform" rating and a $340.00 price target on the stock.
Ratings data for PODD provided by MarketBeat
Insulet Co. (NASDAQ: PODD) had its price target raised by analysts at Oppenheimer Holdings Inc. from $312.00 to $324.00. They now have an "outperform" rating on the stock.
Ratings data for PODD provided by MarketBeat
Insulet Co. (NASDAQ: PODD) was upgraded by analysts at Wolfe Research from a "peer perform" rating to an "outperform" rating. They now have a $350.00 price target on the stock.
Ratings data for PODD provided by MarketBeat
Insulet Co. (NASDAQ: PODD) had its "outperform" rating re-affirmed by analysts at Sanford C. Bernstein.
Ratings data for PODD provided by MarketBeat
Insulet Co. (NASDAQ: PODD) had its price target raised by analysts at Citigroup Inc. from $320.00 to $380.00. They now have a "buy" rating on the stock.
Ratings data for PODD provided by MarketBeat
Insulet Co. (NASDAQ: PODD) had its price target raised by analysts at Raymond James from $328.00 to $360.00. They now have an "outperform" rating on the stock.
Ratings data for PODD provided by MarketBeat
Insulet Co. (NASDAQ: PODD) was upgraded by analysts at Wall Street Zen from a "hold" rating to a "buy" rating.
Ratings data for PODD provided by MarketBeat
Insulet Co. (NASDAQ: PODD) is now covered by analysts at The Goldman Sachs Group, Inc.. They set a "buy" rating and a $380.00 price target on the stock.
Ratings data for PODD provided by MarketBeat
Neueste Beiträge
kevin8888 in Agios Pharmaceuticals Inc. diskutieren